Tirzepatide

Weight Loss In Stock

Tirzepatide

Dual GIP/GLP-1 receptor agonist

$120.00
Dosage
10mg/vial
Packaging
1 vial
Purity
≥99%

Description
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Studied for superior metabolic regulation compared to single agonists.



Research applications include comparative metabolic studies, insulin sensitivity research, and dual-receptor pathway analysis.
Quality Assurance
Purity Analysis — HPLC and Mass Spectrometry verified
Quantitative Testing — Accurate dosing confirmed
USP andlt;71andgt; Sterility — Screened for microbial contamination
Bacterial Endotoxin Panel — Free from harmful toxins
Heavy Metals Screening — Tested for contaminants